Diacomit er indiceret til anvendelse sammen med clobazam og valproat som adjuverende behandling af refraktær generaliserede tonisk- kloniske kramper hos patienter med Dravet syndrome (Severe Myoclonic Epilepsy in Infancy; SMEI), hvis kramper ikke behandles tilstrækkeligt med clobazam og valproat.
Diacomit is indicated for use in conjunction with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (SMEI, Dravet’ s syndrome) whose seizures are not adequately controlled with clobazam and valproate.